India to Philippines: Febuxostat Export Trade Route
India has recorded 446 verified shipments of Febuxostat exported to Philippines, representing a combined trade value of $25.6M USD. This corridor is served by 44 active Indian exporters, with an average shipment value of $57.3K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 58% of total export value with 61 shipments worth $14.9M USD. On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer in Philippines with $7.6M USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, LUPIN LIMITED, AJANTA PHARMA LIMITED — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Febuxostat corridor is one of India's established pharmaceutical export routes, with 446 shipments documented worth a combined $25.6M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's febuxostat manufacturing sector.
Across 44 active suppliers, the average shipment value stands at $57.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with febuxostat's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #5 among India's top febuxostat export destinations globally.
On the import side, key buyers of Indian febuxostat in Philippines include AJANTA PHARMA PHILIPPINES INC, UNILAB INC, MULTICARE PHARMACEUTICALS and 54 others. AJANTA PHARMA PHILIPPINES INC is the single largest importer with 25 shipments valued at $7.6M USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#5
- Annual growth+10.1%
- Demand growth+11.0%
- Regulatory ease76/100
Top 10 Indian Febuxostat Exporters to Philippines
Showing top 10 of 44 Indian suppliers exporting Febuxostat to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED Avg $244.0K per shipment | 61 | $14.9M | 58.2% |
| 2 | LUPIN LIMITED Avg $183.3K per shipment | 20 | $3.7M | 14.3% |
| 3 | AJANTA PHARMA LIMITED Avg $299.7K per shipment | 6 | $1.8M | 7.0% |
| 4 | LUPIN LIMITED Avg $203.9K per shipment | 8 | $1.6M | 6.4% |
| 5 | GLOBELA PHARMA PRIVATE LIMITED Avg $13.8K per shipment | 39 | $536.3K | 2.1% |
| 6 | BDH INDUSTRIES LIMITED Avg $69.7K per shipment | 5 | $348.6K | 1.4% |
| 7 | STALLION LABORATORIES PVT LTD Avg $6.3K per shipment | 54 | $342.8K | 1.3% |
| 8 | AZTEC PHARMA PRIVATE LIMITED Avg $9.5K per shipment | 27 | $256.4K | 1.0% |
| 9 | SUNRISE INTERNATIONAL LABS LIMITED Avg $12.6K per shipment | 19 | $239.8K | 0.9% |
| 10 | GRACURE PHARMACEUTICALS LIMITED Avg $11.3K per shipment | 19 | $215.4K | 0.8% |
This table shows the top 10 of 44 Indian companies exporting febuxostat to Philippines, ranked by total trade value. The listed exporters are: AJANTA PHARMA LIMITED, LUPIN LIMITED, AJANTA PHARMA LIMITED , LUPIN LIMITED , GLOBELA PHARMA PRIVATE LIMITED, BDH INDUSTRIES LIMITED, STALLION LABORATORIES PVT LTD, AZTEC PHARMA PRIVATE LIMITED, SUNRISE INTERNATIONAL LABS LIMITED, GRACURE PHARMACEUTICALS LIMITED. AJANTA PHARMA LIMITED is the dominant supplier with 61 shipments worth $14.9M USD, giving it a 58% market share. The top 3 suppliers together account for 80% of the total trade value on this route.
Showing top 10 of 44 total Indian exporters on the India to Philippines Febuxostat export route.
Top 10 Febuxostat Importers in Philippines
Showing top 10 of 57 known buyers in Philippines receiving Febuxostat shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian febuxostat in Philippines include AJANTA PHARMA PHILIPPINES INC, UNILAB INC, MULTICARE PHARMACEUTICALS , UNILAB INC , MULTICARE PHARMACEUTICALS, among 57 total buyers. The largest importer is AJANTA PHARMA PHILIPPINES INC, accounting for $7.6M USD across 25 shipments — representing 30% of all febuxostat imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA PHILIPPINES INC | 25 | $7.6M | 29.8% |
| 2 | UNILAB INC | 33 | $7.1M | 27.6% |
| 3 | MULTICARE PHARMACEUTICALS | 10 | $2.4M | 9.2% |
| 4 | UNILAB INC | 6 | $1.8M | 7.0% |
| 5 | MULTICARE PHARMACEUTICALS | 10 | $1.6M | 6.1% |
| 6 | MULTICARE PHARMACEUTICALS PHILIPPIN | 7 | $1.2M | 4.5% |
| 7 | TO THE ORDER OF | 26 | $417.7K | 1.6% |
| 8 | OLLEN PHARMA TRADING INC | 4 | $340.2K | 1.3% |
| 9 | TO THE ORDER OF. | 54 | $293.5K | 1.1% |
| 10 | BLISS PHARMA DISTRIBUTION AND CONSU | 17 | $223.2K | 0.9% |
Showing top 10 of 57 Febuxostat importers in Philippines on this route.
Top 10 Febuxostat Formulations Imported by Philippines
Showing top 10 of 349 product formulations shipped on the India to Philippines Febuxostat route, ranked by trade value
Philippines imports a wide range of febuxostat formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — URINORM TAB 40MG FEBUXOSTAT TABLETS 40 — accounts for $1.4M USD across 3 shipments. There are 349 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | URINORM TAB 40MG FEBUXOSTAT TABLETS 40 | 3 | $1.4M | 5.4% |
| 2 | ATENURIX 40[218784PACKx3x10=6563520 TABLETS][EACH FILM COATED TABLET CONTAINS :FEBUXOSTAT 40MG] | 1 | $1.1M | 4.5% |
| 3 | URINORM TAB 40MG (FEBUXOSTAT TABLETS 40 | 3 | $1.1M | 4.2% |
| 4 | FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | 3 | $754.0K | 2.9% |
| 5 | ATENURIX 40[117504PACKx3x10=3525120 TABLETS][EACH FILM COATED TABLET CONTAINS :FEBUXOSTAT 40MG] | 1 | $634.6K | 2.5% |
| 6 | ATENURIX 40 [115776PACKX3X10=3473280 TABS]EACH FILM COATED TAB CONTAINS:FEBUXOSTAT 40MG] | 1 | $608.7K | 2.4% |
| 7 | ATENURIX 40[114048PACK X 3 X 10 = 3421440 TABLETS][EACH FILM COATED TABLET CONTAINS : FEBUXOSTAT 40MG] | 1 | $593.2K | 2.3% |
| 8 | ATENURIX 40 110304PACKx3x10 3309120 TABS EACH FILM COATED TABS CONT FEBUXOSTAT40MG | 1 | $577.6K | 2.3% |
| 9 | ATENURIX 40 [107712packx3x10=3231360 TABLETS][EACH FILM COATED TABLET CONTAINS :FEBUXOSTAT 40MG] | 1 | $555.1K | 2.2% |
| 10 | ATENURIX 40[105297PACKX3X10=3158910 TABS]EACH FILM COATED TAB CONT:FEBUXOSTAT 40MG] | 3 | $551.8K | 2.2% |
Showing top 10 of 349 Febuxostat formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 56 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's febuxostat exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 44 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AJANTA PHARMA LIMITED, LUPIN LIMITED, AJANTA PHARMA LIMITED — together account for 80% of total trade value on this route. The average shipment value of $57.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as atenurix 40[218784packx3x10=6563520 tablets][each film coated tablet contains :febuxostat 40mg] and urinorm tab 40mg (febuxostat tablets 40 , suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer with 25 shipments worth $7.6M USD — representing 30% of all febuxostat imports from India on this route. A total of 57 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $25.6M
- Avg. Shipment
- $57.3K
- Suppliers
- 44
- Buyers
- 57
- Transit (Sea)
- ~28 days
- Annual Growth
- +10.1%
Related Analysis
Other Febuxostat Routes
Unlock the Full India to Philippines Febuxostat Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 446 shipments on this route.
Frequently Asked Questions — India to Philippines Febuxostat Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Febuxostat to Philippines?
The leading Indian exporters of Febuxostat to Philippines are AJANTA PHARMA LIMITED, LUPIN LIMITED, AJANTA PHARMA LIMITED . AJANTA PHARMA LIMITED holds the largest market share at approximately 58% of total trade value on this route.
Q What is the total value of Febuxostat exports from India to Philippines?
India exports Febuxostat to Philippines worth approximately $25.6M USD across 446 recorded shipments. The average value per shipment is $57.3K USD.
Q Which ports does India use to ship Febuxostat to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 56 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Philippines for Febuxostat?
The average transit time for Febuxostat shipments from India to Philippines is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Febuxostat trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.1% with demand growth tracking at 11.0%. The route is ranked #5 among India's top Febuxostat export destinations globally.
Q How many suppliers are active on the India to Philippines Febuxostat route?
There are currently 44 active Indian suppliers exporting Febuxostat to Philippines. The market is moderately concentrated with AJANTA PHARMA LIMITED accounting for 58% of total shipment value.
Q Who are the main importers of Febuxostat from India in Philippines?
The leading importers of Indian Febuxostat in Philippines include AJANTA PHARMA PHILIPPINES INC, UNILAB INC, MULTICARE PHARMACEUTICALS , UNILAB INC , MULTICARE PHARMACEUTICALS. AJANTA PHARMA PHILIPPINES INC is the largest buyer with 25 shipments worth $7.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Febuxostat.
- 2.Supplier/Buyer Matching: 44 Indian exporters and 57 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 446 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
446 Verified Shipments
44 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists